联亚药业

301569
16.004.36% ( -0.73 )
延迟 已收盘: 11月18日 15:00:00

股东

全部股东

股东类型

  • 风投/私募41.35%
  • 私营企业32.11%
  • 个人与内部人士11.27%
  • 机构投资者9.24%
  • 员工持股计划6.04%

主要股东

主要股东 最新
股东
Legend Capital Management Co., Ltd.
19.71%1.76 亿--+1.76 亿
Novast Holdings, Ltd.
19.23%1.71 亿--+1.71 亿
Hainan Shiyu Investment Management Co., Ltd.
12.71%1.13 亿--+1.13 亿
Hui Wang
11.18%9,971.76 万--+9,971.76 万
Xiamen C&D Emerging Industry Equity Investment Co., Ltd.
11.05%9,848.93 万--+9,848.93 万
Xiamen Jianfa Emerging Industries Equity Investment Partnership No. 8 (Limited Partnership)
11.05%9,848.93 万--+9,848.93 万
China Merchants Capital Management Co., Ltd.
4.62%4,115.97 万--+4,115.97 万
China Merchants Capital Investment Co., Ltd.
4.62%4,115.97 万--+4,115.97 万
Jiaxing Xuanyu Equity Investment Partnership (Limited Partnership)
3.47%3,097.36 万--+3,097.36 万
Nantong Lianbo Enterprise Management Partnership (Limited Partnership)
2.10%1,870.18 万--+1,870.18 万
Nantong Lianjia Enterprise Management Partnership (Limited Partnership)
1.08%964.68 万--+964.68 万
Nantong Lianji Enterprise Management Partnership (Limited Partnership)
1.02%905.93 万--+905.93 万
Nantong Lianxi Enterprise Management Partnership (Limited Partnership)
0.95%849.59 万--+849.59 万
Nantong Lianmeng Enterprise Management Partnership (Limited Partnership)
0.70%621.68 万--+621.68 万
Lin Liu
0.66%588.00 万--+588.00 万
CICC Lianyao Pharmaceuticals No. 1 Employee Asset Management Plan
0.50%447.14 万--+447.14 万
Hubei Jiuzhoutong Gaotou Changjiang Industrial Investment Fund Management Co., Ltd.
0.48%428.57 万--+428.57 万